Pfenex Inc
Officers & Directors
1. Eef Schimmelpennink - President & CEO:
Eef Schimmelpennink has been serving as the President & CEO of Pfenex Inc since . He has over 30 years of experience in the biopharmaceutical industry and has held various leadership positions in multiple global life-science companies, including the likes of Novartis, Amgen, and Johnson & Johnson. Eef completed his Master's degree in Pharmacy at the Groningen University in the Netherlands.
2. Susan Knudson - Chief Financial Officer:
Susan Knudson joined Pfenex Inc as the Chief Financial Officer in . Susan has over 25 years of experience in financial management, including CFO roles at multiple biotechnology and medical device companies, such as Accuray Incorporated, Histogen, Inc., and Trius Therapeutics, Inc.
3. Steven Sandoval - Chief Commercial Officer:
Steven Sandoval has been serving as the Chief Commercial Officer of Pfenex since . He has over 25 years of experience in commercialization and marketing for multiple pharmaceutical and biotech companies, including Pfizer and Genentech. Steven has a Bachelor's degree in Political Science from the University of California.
4. Susan Murphy - Chief Development Officer:
Susan Murphy has been serving as the Chief Development Officer of Pfenex since . Susan has over 25 years of experience in drug development and regulatory strategies in various biotech and pharmaceutical companies, including Cytokinetics, Hospira, and Novartis. Susan holds a Ph.D. in Biochemistry from Northwestern University.
Board of Directors:
1. Michael F. Powell - Chairman of the Board:
Michael F. Powell has been serving as the Chairman of the Board of Pfenex since . Michael is the former President and CEO of NRECA (National Rural Electric Cooperative Association) and has held various senior executive roles in several Fortune 500 companies, including Bell Atlantic, AOL Time Warner, and Rand Capital Corporation.
2. Steven B. Singer, M.D.:
Steven B. Singer, M.D., has been serving on the Board of Directors of Pfenex since . He has over 25 years of experience in pharmaceutical product development and commercialization, including roles at Pfizer and Bristol Myers Squibb. Steven holds a Bachelor's degree from Cornell University and an M.D. from the University of Rochester.
3. Bernard F. Coulie, M.D., Ph.D.:
Bernard F. Coulie, M.D., Ph.D., has been serving on the Board of Directors of Pfenex since . Bernard has over 35 years of experience in the biotech and pharmaceutical industry, including various leadership positions at UCB and Barco NV. Bernard holds a Ph.D. in Biochemistry from the University of Louvain in Belgium, and an M.D. from the University of Brussels.
Pfenex Inc currently has 100 employees.
|
